Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
159 Leser
Artikel bewerten:
(0)

EQS-News: LF Asia's healthcare business to become DCH Auriga Serving the healthcare industry with a dedicated Asian distribution platform

Dow Jones received a payment from EQS/DGAP to publish this press release.

EQS-News / 18/10/2017 / 16:45 UTC+8 
 
*LF Asia's healthcare business to become DCH Auriga* 
 
_Serving the healthcare industry with a dedicated Asian distribution 
platform_ 
 
(Hong Kong, 18 October 2017) Following the acquisition of LF Asia Ltd. ("LF 
Asia") and its subsidiaries by Dah Chong Hong Holdings Limited ("DCH", stock 
code: 1828.HK) in July 2016, the LF Asia healthcare and consumer goods 
distribution operations will be realigned under dedicated management to 
prepare for growth across the region. As of 1 Nov 2017, LF Asia's healthcare 
business will change its name to DCH Auriga Ltd. 
 
Under the new name, DCH Auriga will continue to partner with world leading 
healthcare companies to bring medical products and treatments to Asia by 
offering end-to-end solutions including regulatory and medical liaison 
support, sales and marketing, commercial services, warehousing and logistics 
in Hong Kong, Macau, China, Singapore, Malaysia, Indonesia, Thailand and the 
Philippines. 
 
The name "Auriga" is adopted from a constellation depicting a charioteer, 
symbolising the business's commitment to agility and dedication to guiding 
clients through the complexities of dynamic markets. DCH Auriga pairs deeply 
rooted relationships and intrinsic local expertise with cutting edge 
technologies that drive flexibility and transparency in the supply chain. 
This rich expertise is complimented by a dedication to partnership and the 
belief that customised solutions create optimised supply chains. Teams of 
in-market professionals deliver innovative solutions and actionable insights 
to enable our partners to deliver the best possible care to those in need. 
 
Mr. Tim Collins, CEO of DCH Auriga, commented, "This restructuring will 
enable DCH Auriga to focus on better serving our strategic partners across 
the region and meet the unique and complex requirements of Asia's healthcare 
communities. With the support of DCH and CITIC Pacific Limited, we are 
positioned for dynamic growth." 
 
*About DCH Auriga* 
 
DCH Auriga is an an Asia-based integrated market management provider 
specialising in healthcare. Offering comprehensive commercial and logistics 
solutions, DCH Auriga partners with the world's leading healthcare companies 
to distribute pharmaceuticals, medical devices, surgical equipment, 
diagnostics and OTC products for more than 500 brands into hospitals, 
pharmacies and specialty stores across Asia. DCH Auriga is a subsidiary of 
Dah Chong Hong Holdings Limited (stock code: 1828.HK) with operations in 
Hong Kong, Macau, China, Singapore, Malaysia, Indonesia, Thailand and the 
Philippines. For more details, please visit www.dchauriga.com [1]. 
 
*About DCH* 
 
Dah Chong Hong ("DCH", stock code: 1828.HK) is an integrated motor and 
consumer products distribution company operating in Asia with an extensive 
logistics network. DCH is a leading distributor and dealer of motor vehicles 
in Greater China and provides a full range of motor related services 
including maintenance, rental, repair and financing. DCH's consumer products 
business includes the trading, distribution and retail of food and FMCG, 
healthcare and electronic products. 
 
Dedicated to bringing to quality products to consumers across Asia, DCH is 
the preferred partner of over 1,000 brands from more than 30 countries with 
operations in 10 Asian economies. 
 
DCH is a subsidiary of China's largest conglomerate CITIC Limited (stock 
code: 0267.HK), DCH employs over 17,000 staff across the region. For more 
details, please visit www.dch.com.hk [2]. 
 
*Media Enquiries:* 
 
Ms. Gwen Walters 
 
(852) 2768 2017 
 
gwenwalters@dch-holding.com 
 
Ms. Katherine Tung 
 
(852) 2768 2585 
 
katherinetung@cccm.dch.com.hk 
 
Document: http://n.eqs.com/c/fncls.ssp?u=APXBRRORJT [3] 
Document title: LF Asia's healthcare business to become DCH Auriga Serving 
the healthcare industry with a dedicated Asian distribution platform 
 
18/10/2017 Dissemination of a Marketing Press Release, transmitted by EQS 
Group. 
The issuer is solely responsible for the content of this announcement. 
 
Media archive at www.todayir.com 
 
1: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=1c27a8761872916bba2b13325a24e2bc&application_id=619973&site_id=vwd&application_name=news 
2: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=1b5cf047bdeba9ec0dcd6f34ed055817&application_id=619973&site_id=vwd&application_name=news 
3: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=e6a0a04d12a98b503a066f8ac8b9779a&application_id=619973&site_id=vwd&application_name=news 
 

(END) Dow Jones Newswires

October 18, 2017 04:45 ET (08:45 GMT)

© 2017 Dow Jones News
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.